These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Real-life experience after intravitreal ocriplasmin for vitreomacular traction and macular hole: a spectral-domain optical coherence tomography prospective study. Chatziralli I; Theodossiadis G; Parikakis E; Datseris I; Theodossiadis P Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):223-33. PubMed ID: 25940555 [TBL] [Abstract][Full Text] [Related]
4. Intravitreal Injection of Perfluoropropane is More Efficacious than Sulfur Hexafluoride In Releasing Vitreomacular Traction. Čokl N; Globočnik Petrovič M Acta Clin Croat; 2018 Jun; 57(2):327-334. PubMed ID: 30431727 [TBL] [Abstract][Full Text] [Related]
5. [Initial Clinical Experiences Using Ocriplasmin for the Treatment of Vitreomacular Traction with or without a Macular Hole]. Lenk J; Matthé E; Ventzke S; Pillunat LE; Sandner D Klin Monbl Augenheilkd; 2018 Jan; 235(1):73-80. PubMed ID: 28282697 [TBL] [Abstract][Full Text] [Related]
6. Pneumatic Vitreolysis for the Treatment of Vitreomacular Traction Syndrome. Özdemir HB; Özdek Ş; Hasanreisoğlu M Turk J Ophthalmol; 2019 Sep; 49(4):201-208. PubMed ID: 31486607 [TBL] [Abstract][Full Text] [Related]
7. Intravitreal injection of expansile perfluoropropane (c(3)f(8)) for the treatment of vitreomacular traction. Rodrigues IA; Stangos AN; McHugh DA; Jackson TL Am J Ophthalmol; 2013 Feb; 155(2):270-276.e2. PubMed ID: 23164159 [TBL] [Abstract][Full Text] [Related]
8. [Ocriplasmin as a treatment option for symptomatic vitreomacular traction with and without macular hole. First clinical experiences]. Maier M; Abraham S; Frank C; Feucht N; Lohmann CP Ophthalmologe; 2015 Dec; 112(12):990-4. PubMed ID: 26062717 [TBL] [Abstract][Full Text] [Related]
9. Outer retina reflectivity changes on sd-oct after intravitreal ocriplasmin for vitreomacular traction and macular hole. Quezada-Ruiz C; Pieramici DJ; Nasir M; Rabena M; Steinle N; Castellarin AA; Dhoot D; Couvillion S; See RF; Avery RL Retina; 2015 Jun; 35(6):1144-50. PubMed ID: 25961122 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of intravitreal ocriplasmin on vitreomacular traction and full-thickness macular holes. Sharma P; Juhn A; Houston SK; Fineman M; Chiang A; Ho A; Regillo C Am J Ophthalmol; 2015 May; 159(5):861-7.e2. PubMed ID: 25660387 [TBL] [Abstract][Full Text] [Related]
11. Ocriplasmin treatment for vitreomacular traction in real life: can the indication spectrum be expanded? Manousaridis K; Peter-Reichart S; Mennel S Graefes Arch Clin Exp Ophthalmol; 2017 Oct; 255(10):1907-1916. PubMed ID: 28681138 [TBL] [Abstract][Full Text] [Related]
12. Anatomical and visual outcomes following ocriplasmin treatment for symptomatic vitreomacular traction syndrome. Singh RP; Li A; Bedi R; Srivastava S; Sears JE; Ehlers JP; Schachat AP; Kaiser PK Br J Ophthalmol; 2014 Mar; 98(3):356-60. PubMed ID: 24357495 [TBL] [Abstract][Full Text] [Related]